IE43611B1 - Antihypertonic agent - Google Patents

Antihypertonic agent

Info

Publication number
IE43611B1
IE43611B1 IE1580/76A IE158076A IE43611B1 IE 43611 B1 IE43611 B1 IE 43611B1 IE 1580/76 A IE1580/76 A IE 1580/76A IE 158076 A IE158076 A IE 158076A IE 43611 B1 IE43611 B1 IE 43611B1
Authority
IE
Ireland
Prior art keywords
etozolin
antihypertonic
acid
dosage
antihypertensive
Prior art date
Application number
IE1580/76A
Other languages
English (en)
Other versions
IE43611L (en
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of IE43611L publication Critical patent/IE43611L/xx
Publication of IE43611B1 publication Critical patent/IE43611B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IE1580/76A 1975-07-18 1976-07-16 Antihypertonic agent IE43611B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2532180A DE2532180C2 (de) 1975-07-18 1975-07-18 Verwendung von Etozolin bei der Bekämpfung der Hypertonie

Publications (2)

Publication Number Publication Date
IE43611L IE43611L (en) 1977-01-18
IE43611B1 true IE43611B1 (en) 1981-04-08

Family

ID=5951852

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1580/76A IE43611B1 (en) 1975-07-18 1976-07-16 Antihypertonic agent

Country Status (11)

Country Link
AU (1) AU503445B2 (de)
BE (1) BE844210A (de)
CA (1) CA1060344A (de)
DD (1) DD126756A5 (de)
DE (1) DE2532180C2 (de)
GB (1) GB1550393A (de)
GR (1) GR61353B (de)
IE (1) IE43611B1 (de)
LU (1) LU75396A1 (de)
PH (1) PH13059A (de)
ZA (1) ZA763981B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU531659B2 (en) * 1979-03-22 1983-09-01 Goedecke Aktiengesellschaft (+)-(3-methyl-4-oxo - 5n-piperidinothiazolidin-2-ylidene) acetic acid esters

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3072653A (en) * 1961-03-06 1963-01-08 Warner Lamber Pharmaceutical C 5-amino derivatives of 4-thiazolidinones and process therefor

Also Published As

Publication number Publication date
ZA763981B (en) 1977-05-25
IE43611L (en) 1977-01-18
GB1550393A (en) 1979-08-15
DE2532180C2 (de) 1986-12-18
AU1595976A (en) 1978-01-19
GR61353B (en) 1978-10-26
DD126756A5 (de) 1977-08-10
LU75396A1 (de) 1977-02-28
PH13059A (en) 1979-11-21
DE2532180A1 (de) 1977-02-10
AU503445B2 (en) 1979-09-06
BE844210A (fr) 1976-11-16
CA1060344A (en) 1979-08-14

Similar Documents

Publication Publication Date Title
EP0399051B1 (de) Polyvalentes entzündungshemmendes mittel
IE42793B1 (en) Preparation for treatment of colitis
DE3517820C2 (de)
US4428951A (en) Long acting pharmaceutical composition
JPH0140009B2 (de)
US4564625A (en) Binary compositions of penbutolol and furosemide or piretanide
CH667592A5 (de) 9,10-dihydrogenierte ergotalkaloide enthaltende pharmazeutische zusammensetzungen.
JP3982889B2 (ja) イブプロフェン含有医薬製剤
US4515802A (en) Analgesic preparations
AU756338B2 (en) Stabile compositions comprising levosimendan and alginic acid
IE43611B1 (en) Antihypertonic agent
CA1124647A (en) Analgesic potentiation
US3729563A (en) Method of treating movement disorders
JPH0152366B2 (de)
US3949082A (en) Thiadiazoles as anti-inflammatory agents
US3197370A (en) Pyrilamine tannate compositions
JPS6067425A (ja) 制癌剤
US4061747A (en) Antidepressant composition
US4874757A (en) Antinflammatory compositions and methods
US3993778A (en) Anti-ulcerogenic pharmaceutical compositions containing a 2-amino-3,5-dibromo-benzylamine and method of use
US3969508A (en) Lowering the concentration of plasma triglycerides
CA1249521A (en) Antiinflammatory compositions and methods
US4049791A (en) Prolonged acting appetite suppressant and anti-obesity compositions containing amphetamine adipate, dextroamphetamine adipate, amphetamine sulfate and dextroamphetamine sulfate as the active agents
JPH11180884A (ja) 下剤組成物
GB2135884A (en) Analgesic preparations containing tizanidine and paracetamol